Impact of COVID-19 vaccination on COVID-19 hospital admissions in England during 2021: an observational study

Author:

Cornforth Felicity1,Webber Lucie1ORCID,Kerr Gabriele23,Dinsdale Hywell45,Majeed Azeem23ORCID,Greengross Peter14

Affiliation:

1. Imperial College Healthcare NHS Trust, The Bays, St Mary's Hospital, London, W2 1NY, UK

2. NIHR Applied Research Collaboration North West London, Chelsea and Westminster Hospital, London, SW10 9NH, UK

3. Department of Primary Care & Public Health, Imperial College London, London, W6 8RP, UK

4. NHS England, London, SE1 8UG, UK

5. Integral Health Solutions, Daresbury Innovation Centre, Warrington, WA4 4FS, UK

Abstract

Objectives To examine the impact of COVID-19 vaccination on hospital admissions in England in 2021. Design Observational study of emergency admissions for COVID-19 by vaccination status in people 16 years and over in England. Setting Hospitals in England. Participants A total of 48.1 million people registered with an English GP, aged ≥16 years with a recent NHS contact. Main outcome measures Emergency hospital admissions with a primary diagnosis of COVID-19 between 1 January and 31 December 2021. Monthly admission rates were directly standardised for age, sex, risk category and vaccination dose to estimate vaccine effectiveness (VE) over time, between vaccine doses, age groups and risk groups. Results A total of 192,047 hospital admissions were included. The unvaccinated admission rate was higher in December 2021 (6.1 admissions per 100,000 person-days; 95% CI: 5.9 to 6.3) than January 2021 (4.9; 95% CI: 4.9 to 5.0). Vaccinated admission rates were ≤1 per 100,000 from February to December. Doses 1 and 2 VE waned over time, particularly in older and clinically vulnerable groups (although this may reflect that they were vaccinated earlier). Dose 3 VE remained above 93%. Conclusions COVID-19 hospitalisations were consistently highest in the unvaccinated. Despite high case rates at the end of 2021, overall admission rates remained stable, driven by low admission rates among vaccinated people. There is population-level waning in VE, recovering after subsequent doses, potentially more marked in older and at-risk groups. The findings support JCVI (Joint Committee on Vaccination and Immunisation) guidance for an ongoing booster programme, especially in older people and higher clinical risk groups.

Publisher

SAGE Publications

Subject

General Medicine

Reference30 articles.

1. UKHSA. Healthcare in England | Coronavirus in the UK. See https://coronavirus.data.gov.uk/details/healthcare?areaType=nation&areaName=England (last checked 29 April 2022).

2. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

3. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

4. Implementation of covid-19 vaccination in the United Kingdom

5. GOV.uk. COVID-19: the green book, chapter 14a. GOV.UK. See www.gov.uk/government/publications/covid-19-the-green-book-chapter-14a (last checked 3 May 2022).

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3